PURPOSE: To determine the clinical utility of gadolinium-enhanced fluid-att
enuated inversion-recovery (FLAIR) magnetic resonance (MR) imaging of the b
rain by comparing results with those at gadolinium-enhanced T1-weighted MR
imaging with magnetization transfer (MT) saturation.
MATERIALS AND METHODS: In 105 consecutive patients referred for gadolinium-
enhanced brain imaging, FLAIR and T1-weighted MR imaging with MT saturation
were performed before and after administration of gadopentetate dimeglumin
e (0.1 mmol per kilogram of body weight). Pre- and postcontrast images were
evaluated to determine the presence of abnormal contrast enhancement and w
hether enhancement was more conspicuous with the FLAIR or T1-weighted seque
nces.
RESULTS: Thirty-nine studies showed intracranial contrast enhancement. Post
contrast T1-weighted images with MT saturation showed superior enhancement
in 14 studies, whereas postcontrast fast FLAIR images showed superior enhan
cement in 15 studies. Four cases demonstrated approximately equal contrast
enhancement with both sequences. Six cases showed some areas of enhancement
better with T1-weighted imaging with MT saturation and other areas better
with postcontrast fast FLAIR imaging. Superficial enhancement was typically
better seen with postcontrast fast FLAIR imaging.
CONCLUSION: Fast FLAIR images have noticeable T1 contrast making gadolinium
-induced enhancement visible. Gadolinium enhancement in lesions that are hy
perintense on precontrast FLAIR images, such as intraparenchymal tumors, ma
y be better seen on T1-weighted images than on postcontrast fast FLAIR imag
es. However, postcontrast fast FLAIR images may be useful for detecting sup
erficial abnormalities, such as meningeal disease, because they do not demo
nstrate contrast enhancement of vessels with slow flow as do T1-weighted im
ages.